We obtained additional evidence that the consequence of toxic accumulation of amyloid-β (in the brain of patients with the familial form of AD) is a disruption of AβPP processing, whereas in patients with the sporadic form of AD, the accumulation of amyloid-β can be mediated by synaptic processes [48]. The gene discussed is APP; the disease is Alzheimer disease.